Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00035867 · ClinicalTrials.gov registry record · Phase 1
Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
A Phase 1 study, sponsored by Telik.
- Completed
- Registry status
- Phase 1
- Development phase
- 65
- Enrollment target
NCT00035867 is a Phase 1 study that has completed, run by Telik. The registered enrollment target is 65 participants.
The verdict
NCT00035867, a Phase 1 study, has completed, sponsored by Telik.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 65 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and efficacy of TLK199 in patients with myelodysplastic syndrome (MDS).
Interventions
- DRUG TLK199 HCl Liposomes for Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2002-04 |
| Est. Completion | 2007-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00035867
The ClinicalTrials.gov registry entry for NCT00035867 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Telik, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TLK199 HCl Liposomes for Injection is the first listed.
NCT00035867 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00035867 about?
NCT00035867 is a clinical study titled "Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome". The purpose of this study is to determine the safety and efficacy of TLK199 in patients with myelodysplastic syndrome (MDS).
What is the current status of trial NCT00035867?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 65 participants. The study started on 2002-04. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00035867?
The interventions under investigation include: TLK199 HCl Liposomes for Injection (DRUG).
Who is sponsoring clinical trial NCT00035867?
This trial is sponsored by Telik, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.